<PAGE> 1
AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON SEPTEMBER 5, 1996
REGISTRATION NO. 333-8075
- -------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
POST-EFFECTIVE
AMENDMENT NO. 1 TO
FORM S-3
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
TARGET THERAPEUTICS, INC.
(Exact name of Registrant as specified in its charter)
DELAWARE 95-3962471
(State of Incorporation) (I.R.S. Employer Identification No.)
47201 LAKEVIEW BLVD.
FREMONT, CA 94538
(Address of principal executive offices)
GARY R. BANG
PRESIDENT AND CHIEF EXECUTIVE OFFICER
TARGET THERAPEUTICS, INC.
47201 LAKEVIEW BLVD.
FREMONT, CA 94538
(510) 440-7700
(Name, address and telephone number of agent for service)
COPIES TO:
MICHAEL W. HALL
VENTURE LAW GROUP
A PROFESSIONAL CORPORATION
2800 SAND HILL ROAD
MENLO PARK, CALIFORNIA 94025
(415) 854-4488
--------------
If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, please check the following
box and list the Securities Act registration number of the earlier effective
registration statement for the same offering. / /
If this Form is a post-effective amendment filed pursuant to Rule
462(c) under the Securities Act, check the following box and list the
Securities Act registration number of the earlier effective registration
statement for the same offering. / /
If delivery of the prospectus is expected to be made pursuant to Rule
434, please check the following box. / /
--------------
<PAGE> 2
The Registrant hereby withdraws from registration 115,505 shares of its
Common Stock out of a total of 143,775 shares of its Common Stock previously
registered pursuant to this Registration Statement. The Registration Statement
is hereby amended, as appropriate, to reflect the deregistration of those shares
not sold on or before the date of this Post-Effective Amendment No. 1 to the
Registration Statement.
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
Registrant, Target Therapeutics, Inc., a Delaware corporation, certifies that
it has reasonable grounds to believe that it meets all of the requirements for
filing on Form S-3 and has duly caused this Amendment to the Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Fremont, State of California, on September 4, 1996.
TARGET THERAPEUTICS, INC.
By /s/ Robert E. McNamara
------------------------------------
Robert E. McNamara, Vice President,
Finance and Administration, Chief
Financial Officer and Assistant
Secretary
Pursuant to the requirements of the Securities Act of 1933, this
Amendment to the Registration Statement has been signed by the following
persons in the capacities and on the dates indicated.
Signature Title Date
--------- ----- ----
/s/ Gary R. Bang* President, Chief Executive September 4, 1996
- ----------------------- Officer and Director
(Gary R. Bang) (Principal Executive Officer)
/s/ Robert E. McNamara
- ----------------------- Vice President, Finance and September 4, 1996
(Robert E. McNamara) Administration, Chief
Financial Officer and
Assistant Secretary
(Principal Financial and
Accounting Officer)
/s/ Charles M. Strother* Chairman of the Board of September 4, 1996
- ----------------------- Directors
(Charles M. Strother)
/s/ William G. Davis* Director September 4, 1996
- -----------------------
(William G. Davis)
/s/ Kathleen Murray* Director September 4, 1996
- -----------------------
(Kathleen Murray, M.S.N.)
/s/ Howard D. Palefsky* Director September 4, 1996
- -----------------------
(Howard D. Palefsky)
/s/ Richard D. Randall* Director September 4, 1996
- -----------------------
(Richard D. Randall)
/s/ John C. Villforth* Director September 4, 1996
- -----------------------
(John C. Villforth)
*By: /s/ Robert E. McNamara
-----------------------
(Robert E. McNamara)
(Attorney-in-fact)
